Vaccines against Plasmodium vivax: a research challenge. (Q38062029)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Vaccines against Plasmodium vivax: a research challenge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

0 references

Manuel-Alfonso Patarroyo

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Darwin A Moreno-Perez

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Dayana Calderón

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

18 February 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

1249-1260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites

18 February 2020

cites work

1 reference

Determination of the Plasmodium vivax schizont stage proteome

21 January 2018

1 reference

Comparative genomics of the neglected human malaria parasite Plasmodium vivax

21 January 2018

1 reference

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

21 January 2018

1 reference

A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites

21 January 2018

1 reference

Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.

21 January 2018

1 reference

Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.

21 January 2018

1 reference

Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria

21 January 2018

1 reference

Use of long synthetic peptides to study the antigenicity and immunogenicity of the Plasmodium vivax circumsporozoite protein.

21 January 2018

1 reference

Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51

21 January 2018

1 reference

Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors

21 January 2018

1 reference

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

21 January 2018

1 reference

Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine

21 January 2018

1 reference

Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design

21 January 2018

1 reference

Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys

21 January 2018

1 reference

Preclinical assessment of the receptor-binding domain of Plasmodium vivax Duffy-binding protein as a vaccine candidate in rhesus macaques.

21 January 2018

1 reference

Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys.

21 January 2018

1 reference

A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.

21 January 2018

1 reference

The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys.

21 January 2018

1 reference

Immunogenicity and protection-inducing ability of recombinant Plasmodium vivax rhoptry-associated protein 2 in Aotus monkeys: a potential vaccine candidate.

21 January 2018

1 reference

Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli.

21 January 2018

1 reference

Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection

21 January 2018

1 reference

Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein.

21 January 2018

1 reference

Evaluation of the antigenicity of universal epitopes from PvDBPII in individuals exposed to Plasmodium vivax malaria.

21 January 2018

1 reference

Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice

21 January 2018

1 reference

Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).

21 January 2018

1 reference

Expression, polymorphism analysis, reticulocyte binding and serological reactivity of two Plasmodium vivax MSP-1 protein recombinant fragments.

21 January 2018

1 reference

Splenectomised and spleen intact Aotus monkeys' immune response to Plasmodium vivax MSP-1 protein fragments and their high activity binding peptides.

21 January 2018

1 reference

Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells

21 January 2018

1 reference

Plasmodium vivax: functional analysis of a highly conserved PvRBP-1 protein region

21 January 2018

1 reference

The Plasmodium vivax rhoptry-associated protein 1.

21 January 2018

1 reference

Identification and characterisation of the Plasmodium vivax rhoptry-associated protein 2.

21 January 2018

1 reference

Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue.

21 January 2018

1 reference

Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy

21 January 2018

1 reference

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria

21 January 2018

1 reference

Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

21 January 2018

1 reference

Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate

21 January 2018

1 reference

Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays

21 January 2018

1 reference

Genome comparison of human and non-human malaria parasites reveals species subset-specific genes potentially linked to human disease

21 January 2018

1 reference

Plasmodium vivax merozoite surface protein 8 cloning, expression, and characterisation

21 January 2018

1 reference

Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34kDa rhoptry antigen (Pv34).

21 January 2018

1 reference

Characterisation of the Plasmodium vivax Pv38 antigen

21 January 2018

1 reference

Identification, characterization and antigenicity of the Plasmodium vivax rhoptry neck protein 1 (PvRON1).

21 January 2018

1 reference

Cloning, expression, and characterisation of a Plasmodium vivax MSP7 family merozoite surface protein

21 January 2018

1 reference

The Plasmodium vivax Pv41 surface protein: identification and characterization.

21 January 2018

1 reference

Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein

21 January 2018

1 reference

Identifying and characterizing a member of the RhopH1/Clag family in Plasmodium vivax

21 January 2018

1 reference

PvRON2, a new Plasmodium vivax rhoptry neck antigen

21 January 2018

1 reference

Identifying and characterising the Plasmodium falciparum RhopH3 Plasmodium vivax homologue.

21 January 2018

1 reference

Expression and purification of a Plasmodium vivax antigen - PvTARAg55 tryptophan- and alanine-rich antigen and its immunological responses in human subjects

21 January 2018

1 reference

High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74).

21 January 2018

1 reference

B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon

21 January 2018

1 reference

Cultivation of Plasmodium vivax

21 January 2018

1 reference

Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax

21 January 2018

1 reference

A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax

21 January 2018

1 reference

Plasmodium vivax MSP-1 peptides have high specific binding activity to human reticulocytes.

21 January 2018

1 reference

Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development

21 January 2018

1 reference

Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates

21 January 2018

1 reference

Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3alpha from the malaria parasite Plasmodium vivax in Thailand.

21 January 2018

1 reference

High polymorphism in Plasmodium vivax merozoite surface protein-5 (MSP5).

21 January 2018

1 reference

Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from Myanmar

21 January 2018

1 reference

Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines

21 January 2018

1 reference

Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition

21 January 2018

1 reference

Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein

21 January 2018

1 reference

Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean children

21 January 2018

1 reference

Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.

21 January 2018

1 reference

Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival

21 January 2018

1 reference

Further understanding the nature of relapse of Plasmodium vivax infection.

21 January 2018

1 reference

Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals

21 January 2018

1 reference

The first Plasmodium vivax relapses of life are usually genetically homologous

21 January 2018

1 reference

Plasmodium vivax: who cares?

21 January 2018

1 reference

The pathogenic basis of malaria

21 January 2018

1 reference

A highly infective Plasmodium vivax strain adapted to Aotus monkeys: quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development

21 January 2018

1 reference

Identification of Plasmodium vivax proteins with potential role in invasion using sequence redundancy reduction and profile hidden Markov models

21 January 2018

1 reference

Structural and immunological principles leading to chemically synthesized, multiantigenic, multistage, minimal subunit-based vaccine development.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json

release_7geh23r3vvbqjktn4zvvhgm3ha

18 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7geh23r3vvbqjktn4zvvhgm3ha

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23176656%20AND%20SRC:MED&resulttype=core&format=json